Skip to content

Exalt D Single-use Duodenoscope in ERCP Procedures in China

Real World Study of Exalt D Single-use Duodenoscope in ERCP Procedures in China

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04687774
Acronym
ExaltDScope
Enrollment
0
Registered
2020-12-29
Start date
2022-08-31
Completion date
2022-10-31
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholangiopancreatography

Keywords

ERCP

Brief summary

Study Objective(s):This study is to evaluate the feasibility, preliminary safety and performance of Exalt D Single-use Duodenoscope in ERCP procedures in China, to generate local real world data from a Chinese ERCP population. Study Design:Prospective, single-arm study Planned Number of Subjects:Up to 35 to satisfy 30 treated cohort Primary Endpoint:Ability to complete the ERCP procedure for the intended indication(s) without crossing to reusable duodenoscope. It is also considered as Exalt D's ability if the clinical effect is the same per the investigator's judgement in case of an endoscope change (non-Exalt D).

Detailed description

Device Description:The Exalt™ Model D Single-Use Duodenoscope is a sterile, single-use endoscope that facilitates access to the duodenum, delivery of accessories, and live video when connected to an Exalt™ Controller. The Exalt™ Controller is an electronic device that: * Receives video signals from a Boston Scientific single-use endoscope, * Processes the video signals, * Outputs video images to a video monitor, and * Outputs electrical signal(s) that interface with external image capture systems. Study Design:This is a prospective, single-arm study with up to 35 subjects to satisfy 30 treated cohort in up to 3 centers. The study duration is expected to be approximately 7 months, assuming 6 months enrollment and 1 month follow up. The study duration for each subject is expected to be approximately 30 days. Data Analyses:All statistical analyses will be done using The SAS System software, version 8 or higher (Copyright © 2000 SAS Institute Inc., SAS Campus Drive, Cary, North Carolina 27513, USA. All rights reserved).

Interventions

DEVICEExaltTM Model D Single-Use Duodenoscope

The Exalt™ Model D Single-Use Duodenoscope is a sterile, single-use endoscope that facilitates access to the duodenum, delivery of accessories, and live video when connected to an Exalt™ Controller.

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 18 years or older 2. Willing and able to comply with the study procedures and provide written informed consent to participate in the study 3. Schedule for a clinically indicated ERCP

Exclusion criteria

1. Potentially vulnerable subjects, including, but not limited to pregnant women 2. Subjects for whom endoscopic techniques are contraindicated 3. Subjects who are currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor 4. Investigator discretion

Design outcomes

Primary

MeasureTime frameDescription
Number of patients complete the ERCP procedureDuring the procedureAbility to complete the ERCP procedure for the intended indication(s) without crossing to reusable duodenoscope. It is also considered as Exalt D's ability if the clinical effect is the same per the investigator's judgement in case of an endoscope change (non-Exalt D).

Secondary

MeasureTime frameDescription
Endoscopist qualitative ratingDuring the procedureEndoscopist rating of the Exalt single-use duodenoscope compared to their past experience with marketed reusable duodenoscopes as it pertains to various design and performance related attributes. Besides those criteria similar to Exalt DScope 01 study, assessment in this study will include imaging quality (brightness, color, photometry), overall maneuverability and overall satisfaction, which will be rated from 1-10, where 1 is the worst and 10 is the best.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026